H.R. 6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023

Bill · 117th Congress (2021–2022). Became law, 30 Sep 2022 · Public Law 117-180. Introduced 25 Feb 2022.

Official title: Making continuing appropriations for fiscal year 2023, and for other purposes.

Vote results

House, 30 Sep 2022: Passed, 230 Yea, 201 Nay, 0 Present, 2 Not voting. The House’s roll call
Senate, 29 Sep 2022: Bill Passed, 72 Yea, 25 Nay, 0 Present, 3 Not voting. The Senate’s roll call
President: Signed 30 Sep 2022 · Public Law 117-180

How each member voted

White House

Signed (1): Joseph Biden (D, President).

Not in office (2): Donald Trump (R, President); Mike Pence (R, Vice President).

Senate

Yea (72): Chuck Grassley (R-IA); Patrick J. Leahy (D-VT); Edward J. Markey (D-MA); Richard C. Shelby (R-AL); Charles E. Schumer (D-NY); Ron Wyden (D-OR); Richard J. Durbin (D-IL); Mitch McConnell (R-KY); Benjamin L. Cardin (D-MD); Thomas R. Carper (D-DE); Jack Reed (D-RI); Bernard Sanders (I-VT); Dianne Feinstein (D-CA); Sherrod Brown (D-OH); Patty Murray (D-WA); Robert Menendez (D-NJ); Richard Burr (R-NC); Lindsey Graham (R-SC); Roger F. Wicker (R-MS); Roy Blunt (R-MO); Susan M. Collins (R-ME); Jerry Moran (R-KS); Debbie Stabenow (D-MI); Tammy Baldwin (D-WI); Maria Cantwell (D-WA); Shelley Moore Capito (R-WV); John Boozman (R-AR); John Cornyn (R-TX); Lisa Murkowski (R-AK); Chris Van Hollen (D-MD); Robert P. Casey, Jr. (D-PA); Kirsten E. Gillibrand (D-NY); Mazie K. Hirono (D-HI); Amy Klobuchar (D-MN); Christopher Murphy (D-CT); Jon Tester (D-MT); Sheldon Whitehouse (D-RI); Bill Cassidy (R-LA); Martin Heinrich (D-NM); Ben Ray Luján (D-NM); Jeff Merkley (D-OR); Gary C. Peters (D-MI); Jeanne Shaheen (D-NH); Mark R. Warner (D-VA); Michael F. Bennet (D-CO); Christopher A. Coons (D-DE); Joe Manchin, III (D-WV); Richard Blumenthal (D-CT); Todd Young (R-IN); Brian Schatz (D-HI); Tom Cotton (R-AR); Tammy Duckworth (D-IL); Tim Kaine (D-VA); Angus S. King, Jr. (I-ME); Kyrsten Sinema (I-AZ); Elizabeth Warren (D-MA); Cory A. Booker (D-NJ); Joni Ernst (R-IA); Dan Sullivan (R-AK); Thom Tillis (R-NC); Catherine Cortez Masto (D-NV); Margaret Wood Hassan (D-NH); John Kennedy (R-LA); Jacky Rosen (D-NV); Tina Smith (D-MN); Cindy Hyde-Smith (R-MS); Mitt Romney (R-UT); Mark Kelly (D-AZ); John W. Hickenlooper (D-CO); Jon Ossoff (D-GA); Alex Padilla (D-CA); Raphael G. Warnock (D-GA).

Nay (25): James M. Inhofe (R-OK); Mike Crapo (R-ID); John Thune (R-SD); Marsha Blackburn (R-TN); Patrick J. Toomey (R-PA); John Barrasso (R-WY); James E. Risch (R-ID); John Hoeven (R-ND); Ron Johnson (R-WI); James Lankford (R-OK); Rand Paul (R-KY); Tim Scott (R-SC); Kevin Cramer (R-ND); Ted Cruz (R-TX); Steve Daines (R-MT); Deb Fischer (R-NE); Cynthia M. Lummis (R-WY); Mike Rounds (R-SD); Ben Sasse (R-NE); Roger Marshall (R-KS); Mike Braun (R-IN); Josh Hawley (R-MO); Rick Scott (R-FL); Bill Hagerty (R-TN); Tommy Tuberville (R-AL).

Not voting (3): Rob Portman (R-OH); Mike Lee (R-UT); Marco Rubio (R-FL).

Not in office (2): Kamala D. Harris (D-CA); Kelly Loeffler (R-GA).

House

Yea (230): Harold Rogers (R-KY-5); Steny H. Hoyer (D-MD-5); Marcy Kaptur (D-OH-9); Peter A. DeFazio (D-OR-4); Fred Upton (R-MI-6); Nancy Pelosi (D-CA-12); Frank Pallone, Jr. (D-NJ-6); Richard E. Neal (D-MA-1); David E. Price (D-NC-4); Jim Cooper (D-TN-5); Rosa L. DeLauro (D-CT-3); Maxine Waters (D-CA-43); Jerrold Nadler (D-NY-10); Sanford D. Bishop, Jr. (D-GA-2); James E. Clyburn (D-SC-6); Anna G. Eshoo (D-CA-18); Eddie Bernice Johnson (D-TX-30); Carolyn B. Maloney (D-NY-12); Lucille Roybal-Allard (D-CA-40); Bobby L. Rush (D-IL-1); Robert C. "Bobby" Scott (D-VA-3); Nydia M. Velázquez (D-NY-7); Bennie G. Thompson (D-MS-2); Lloyd Doggett (D-TX-35); Sheila Jackson Lee (D-TX-18); Zoe Lofgren (D-CA-19); Earl Blumenauer (D-OR-3); Danny K. Davis (D-IL-7); Diana DeGette (D-CO-1); Ron Kind (D-WI-3); James P. McGovern (D-MA-2); Bill Pascrell, Jr. (D-NJ-9); Brad Sherman (D-CA-30); Adam Smith (D-WA-9); Gregory W. Meeks (D-NY-5); Barbara Lee (D-CA-13); John B. Larson (D-CT-1); Grace F. Napolitano (D-CA-32); Janice D. Schakowsky (D-IL-9); Mike Thompson (D-CA-5); James R. Langevin (D-RI-2); Rick Larsen (D-WA-2); Betty McCollum (D-MN-4); Adam B. Schiff (D-CA-28); Stephen F. Lynch (D-MA-8); Raúl M. Grijalva (D-AZ-3); C. A. Dutch Ruppersberger (D-MD-2); Tim Ryan (D-OH-13); David Scott (D-GA-13); Linda T. Sánchez (D-CA-38); Emanuel Cleaver (D-MO-5); Jim Costa (D-CA-16); Henry Cuellar (D-TX-28); Al Green (D-TX-9); Brian Higgins (D-NY-26); Patrick T. McHenry (R-NC-10); Gwen Moore (D-WI-4); Debbie Wasserman Schultz (D-FL-23); Doris O. Matsui (D-CA-6); Albio Sires (D-NJ-8); Kathy Castor (D-FL-14); Yvette D. Clarke (D-NY-9); Steve Cohen (D-TN-9); Joe Courtney (D-CT-2); Henry C. "Hank" Johnson, Jr. (D-GA-4); Jerry McNerney (D-CA-9); Ed Perlmutter (D-CO-7); John P. Sarbanes (D-MD-3); Peter Welch (D-VT-AL); John A. Yarmuth (D-KY-3); André Carson (D-IN-7); Jackie Speier (D-CA-14); Gerald E. Connolly (D-VA-11); James A. Himes (D-CT-4); Chellie Pingree (D-ME-1); Paul Tonko (D-NY-20); Kurt Schrader (D-OR-5); Mike Quigley (D-IL-5); Judy Chu (D-CA-27); John Garamendi (D-CA-3); Bill Foster (D-IL-11); Karen Bass (D-CA-37); David N. Cicilline (D-RI-1); William R. Keating (D-MA-9); Adam Kinzinger (R-IL-16); Terri A. Sewell (D-AL-7); Frederica S. Wilson (D-FL-24); Steve Womack (R-AR-3); Dina Titus (D-NV-1); Kweisi Mfume (D-MD-7); Suzanne Bonamici (D-OR-1); Suzan K. DelBene (D-WA-1); Donald M. Payne, Jr. (D-NJ-10); Joyce Beatty (D-OH-3); Ami Bera (D-CA-7); Julia Brownley (D-CA-26); Cheri Bustos (D-IL-17); Matt Cartwright (D-PA-8); Joaquin Castro (D-TX-20); Tony Cárdenas (D-CA-29); Lois Frankel (D-FL-21); Jared Huffman (D-CA-2); Hakeem S. Jeffries (D-NY-8); Daniel T. Kildee (D-MI-5); Derek Kilmer (D-WA-6); Ann Kirkpatrick (D-AZ-2); Ann M. Kuster (D-NH-2); Alan S. Lowenthal (D-CA-47); Sean Patrick Maloney (D-NY-18); Grace Meng (D-NY-6); Mark Pocan (D-WI-2); Raul Ruiz (D-CA-36); Eric Swalwell (D-CA-15); Mark Takano (D-CA-41); Juan Vargas (D-CA-51); Marc A. Veasey (D-TX-33); Robin L. Kelly (D-IL-2); Katherine M. Clark (D-MA-5); Alma S. Adams (D-NC-12); Donald Norcross (D-NJ-1); Pete Aguilar (D-CA-31); Donald S. Beyer, Jr. (D-VA-8); Brendan F. Boyle (D-PA-2); Ed Case (D-HI-1); Mark DeSaulnier (D-CA-11); Debbie Dingell (D-MI-12); Ruben Gallego (D-AZ-7); Garret Graves (R-LA-6); John Katko (R-NY-24); Brenda L. Lawrence (D-MI-14); Ted Lieu (D-CA-33); Seth Moulton (D-MA-6); Kathleen M. Rice (D-NY-4); Norma J. Torres (D-CA-35); Bonnie Watson Coleman (D-NJ-12); Bradley Scott Schneider (D-IL-10); Dwight Evans (D-PA-3); Nanette Diaz Barragán (D-CA-44); Lisa Blunt Rochester (D-DE-AL); Anthony G. Brown (D-MD-4); Salud O. Carbajal (D-CA-24); J. Luis Correa (D-CA-46); Val Butler Demings (D-FL-10); Adriano Espaillat (D-NY-13); Brian K. Fitzpatrick (R-PA-1); Vicente Gonzalez (D-TX-15); Josh Gottheimer (D-NJ-5); Steven Horsford (D-NV-4); Pramila Jayapal (D-WA-7); Ro Khanna (D-CA-17); Raja Krishnamoorthi (D-IL-8); Al Lawson, Jr. (D-FL-5); Stephanie N. Murphy (D-FL-7); Tom O’Halleran (D-AZ-1); Jimmy Panetta (D-CA-20); Jamie Raskin (D-MD-8); Darren Soto (D-FL-9); Thomas R. Suozzi (D-NY-3); Jimmy Gomez (D-CA-34); Conor Lamb (D-PA-17); Joseph D. Morelle (D-NY-25); Mary Gay Scanlon (D-PA-5); Susan Wild (D-PA-7); Colin Z. Allred (D-TX-32); Cynthia Axne (D-IA-3); Sean Casten (D-IL-6); Angie Craig (D-MN-2); Jason Crow (D-CO-6); Sharice Davids (D-KS-3); Madeleine Dean (D-PA-4); Veronica Escobar (D-TX-16); Lizzie Fletcher (D-TX-7); Sylvia R. Garcia (D-TX-29); Jesús G. "Chuy" García (D-IL-4); Jared F. Golden (D-ME-2); Anthony Gonzalez (R-OH-16); Josh Harder (D-CA-10); Jahana Hayes (D-CT-5); Chrissy Houlahan (D-PA-6); Andy Kim (D-NJ-3); Susie Lee (D-NV-3); Andy Levin (D-MI-9); Mike Levin (D-CA-49); Elaine G. Luria (D-VA-2); Tom Malinowski (D-NJ-7); Lucy McBath (D-GA-6); Joe Neguse (D-CO-2); Alexandria Ocasio-Cortez (D-NY-14); Ilhan Omar (D-MN-5); Chris Pappas (D-NH-1); Dean Phillips (D-MN-3); Katie Porter (D-CA-45); Ayanna Pressley (D-MA-7); Kim Schrier (D-WA-8); Mikie Sherrill (D-NJ-11); Elissa Slotkin (D-MI-8); Abigail Davis Spanberger (D-VA-7); Greg Stanton (D-AZ-9); Haley M. Stevens (D-MI-11); Rashida Tlaib (D-MI-13); Lori Trahan (D-MA-3); David J. Trone (D-MD-6); Lauren Underwood (D-IL-14); Jennifer Wexton (D-VA-10); Chris Jacobs (R-NY-27); Jake Auchincloss (D-MA-4); Carolyn Bourdeaux (D-GA-7); Jamaal Bowman (D-NY-16); Cori Bush (D-MO-1); Sara Jacobs (D-CA-53); Mondaire Jones (D-NY-17); Kaiali’i Kahele (D-HI-2); Teresa Leger Fernandez (D-NM-3); Kathy E. Manning (D-NC-6); Frank J. Mrvan (D-IN-1); Marie Newman (D-IL-3); Deborah K. Ross (D-NC-2); Marilyn Strickland (D-WA-10); Ritchie Torres (D-NY-15); Nikema Williams (D-GA-5); Troy A. Carter (D-LA-2); Melanie A. Stansbury (D-NM-1); Shontel M. Brown (D-OH-11); Sheila Cherfilus-McCormick (D-FL-20); Mary Sattler Peltola (D-AK-AL); Patrick Ryan (D-NY-19); Michael F. Doyle (D-PA-18); G. K. Butterfield (D-NC-1); Theodore E. Deutch (D-FL-22); A. Donald McEachin (D-VA-4).

Nay (201): Christopher H. Smith (R-NJ-4); Ken Calvert (R-CA-42); Frank D. Lucas (R-OK-3); Steve Chabot (R-OH-1); Robert B. Aderholt (R-AL-4); Kevin Brady (R-TX-8); Kay Granger (R-TX-12); Michael K. Simpson (R-ID-2); Pete Sessions (R-TX-17); Sam Graves (R-MO-6); Joe Wilson (R-SC-2); Michael C. Burgess (R-TX-26); John R. Carter (R-TX-31); Tom Cole (R-OK-4); Mario Diaz-Balart (R-FL-25); Mike Rogers (R-AL-3); Michael R. Turner (R-OH-10); Darrell Issa (R-CA-50); Virginia Foxx (R-NC-5); Louie Gohmert (R-TX-1); Michael T. McCaul (R-TX-10); Cathy McMorris Rodgers (R-WA-5); Gus M. Bilirakis (R-FL-12); Vern Buchanan (R-FL-16); Jim Jordan (R-OH-4); Doug Lamborn (R-CO-5); Kevin McCarthy (R-CA-23); Adrian Smith (R-NE-3); Robert E. Latta (R-OH-5); Robert J. Wittman (R-VA-1); Steve Scalise (R-LA-1); Tim Walberg (R-MI-7); Brett Guthrie (R-KY-2); Blaine Luetkemeyer (R-MO-3); Tom McClintock (R-CA-4); Bill Posey (R-FL-8); Glenn Thompson (R-PA-15); Mo Brooks (R-AL-5); Larry Bucshon (R-IN-8); Eric A. "Rick" Crawford (R-AR-1); Scott DesJarlais (R-TN-4); Jeff Duncan (R-SC-3); Charles J. "Chuck" Fleischmann (R-TN-3); Bob Gibbs (R-OH-7); Paul A. Gosar (R-AZ-4); H. Morgan Griffith (R-VA-9); Andy Harris (R-MD-1); Vicky Hartzler (R-MO-4); Jaime Herrera Beutler (R-WA-3); Bill Huizenga (R-MI-2); Bill Johnson (R-OH-6); Mike Kelly (R-PA-16); Billy Long (R-MO-7); David B. McKinley (R-WV-1); Steven M. Palazzo (R-MS-4); David Schweikert (R-AZ-6); Austin Scott (R-GA-8); Daniel Webster (R-FL-11); Mark E. Amodei (R-NV-2); Thomas Massie (R-KY-4); Andy Barr (R-KY-6); Rodney Davis (R-IL-13); Richard Hudson (R-NC-8); David P. Joyce (R-OH-14); Doug LaMalfa (R-CA-1); Markwayne Mullin (R-OK-2); Scott Perry (R-PA-10); Tom Rice (R-SC-7); Chris Stewart (R-UT-2); Ann Wagner (R-MO-2); Randy K. Weber, Sr. (R-TX-14); Brad R. Wenstrup (R-OH-2); Roger Williams (R-TX-25); Jason Smith (R-MO-8); Rick W. Allen (R-GA-12); Brian Babin (R-TX-36); Mike Bost (R-IL-12); Ken Buck (R-CO-4); Earl L. "Buddy" Carter (R-GA-1); Tom Emmer (R-MN-6); Glenn Grothman (R-WI-6); Jody B. Hice (R-GA-10); J. French Hill (R-AR-2); Barry Loudermilk (R-GA-11); John R. Moolenaar (R-MI-4); Alexander X. Mooney (R-WV-2); Dan Newhouse (R-WA-4); Gary J. Palmer (R-AL-6); David Rouzer (R-NC-7); Elise M. Stefanik (R-NY-21); Bruce Westerman (R-AR-4); David G. Valadao (R-CA-21); Trent Kelly (R-MS-1); Darin LaHood (R-IL-18); Warren Davidson (R-OH-8); James Comer (R-KY-1); Jodey C. Arrington (R-TX-19); Don Bacon (R-NE-2); Jim Banks (R-IN-3); Jack Bergman (R-MI-1); Andy Biggs (R-AZ-5); Ted Budd (R-NC-13); Liz Cheney (R-WY-AL); Neal P. Dunn (R-FL-2); A. Drew Ferguson IV (R-GA-3); Matt Gaetz (R-FL-1); Mike Gallagher (R-WI-8); Clay Higgins (R-LA-3); Trey Hollingsworth (R-IN-9); Mike Johnson (R-LA-4); David Kustoff (R-TN-8); Brian J. Mast (R-FL-18); John H. Rutherford (R-FL-4); Lloyd Smucker (R-PA-11); Ron Estes (R-KS-4); Ralph Norman (R-SC-5); John R. Curtis (R-UT-3); Debbie Lesko (R-AZ-8); Michael Cloud (R-TX-27); Troy Balderson (R-OH-12); Kevin Hern (R-OK-1); Kelly Armstrong (R-ND-AL); James R. Baird (R-IN-4); Tim Burchett (R-TN-2); Ben Cline (R-VA-6); Dan Crenshaw (R-TX-2); Russ Fulcher (R-ID-1); Lance Gooden (R-TX-5); Mark E. Green (R-TN-7); Michael Guest (R-MS-3); Dusty Johnson (R-SD-AL); John Joyce (R-PA-13); Daniel Meuser (R-PA-9); Carol D. Miller (R-WV-3); Greg Pence (R-IN-6); Guy Reschenthaler (R-PA-14); John W. Rose (R-TN-6); Chip Roy (R-TX-21); Pete Stauber (R-MN-8); Bryan Steil (R-WI-1); W. Gregory Steube (R-FL-17); Van Taylor (R-TX-3); William R. Timmons IV (R-SC-4); Jefferson Van Drew (R-NJ-2); Michael Waltz (R-FL-6); Claudia Tenney (R-NY-22); Fred Keller (R-PA-12); Dan Bishop (R-NC-9); Gregory F. Murphy (R-NC-3); Mike Garcia (R-CA-25); Thomas P. Tiffany (R-WI-7); Cliff Bentz (R-OR-2); Stephanie I. Bice (R-OK-5); Lauren Boebert (R-CO-3); Kat Cammack (R-FL-3); Jerry L. Carl (R-AL-1); Madison Cawthorn (R-NC-11); Andrew S. Clyde (R-GA-9); Byron Donalds (R-FL-19); Pat Fallon (R-TX-4); Randy Feenstra (R-IA-4); Michelle Fischbach (R-MN-7); Scott Fitzgerald (R-WI-5); Scott Franklin (R-FL-15); Andrew R. Garbarino (R-NY-2); Carlos A. Gimenez (R-FL-26); Tony Gonzales (R-TX-23); Bob Good (R-VA-5); Marjorie Taylor Greene (R-GA-14); Diana Harshbarger (R-TN-1); Yvette Herrell (R-NM-2); Ashley Hinson (R-IA-1); Ronny Jackson (R-TX-13); Young Kim (R-CA-39); Jake LaTurner (R-KS-2); Nancy Mace (R-SC-1); Nicole Malliotakis (R-NY-11); Tracey Mann (R-KS-1); Lisa C. McClain (R-MI-10); Peter Meijer (R-MI-3); Mary E. Miller (R-IL-15); Mariannette Miller-Meeks (R-IA-2); Barry Moore (R-AL-2); Blake D. Moore (R-UT-1); Troy E. Nehls (R-TX-22); Jay Obernolte (R-CA-8); Burgess Owens (R-UT-4); August Pfluger (R-TX-11); Matthew M. Rosendale, Sr. (R-MT-AL); Maria Elvira Salazar (R-FL-27); Victoria Spartz (R-IN-5); Michelle Steel (R-CA-48); Beth Van Duyne (R-TX-24); Julia Letlow (R-LA-5); Jake Ellzey (R-TX-6); Mike Carey (R-OH-15); Connie Conway (R-CA-22); Mayra Flores (R-TX-34); Mike Flood (R-NE-1); Brad Finstad (R-MN-1); Joseph Sempolinski (R-NY-23).

Not voting (2): Scott H. Peters (D-CA-52); Lee M. Zeldin (R-NY-1).

Not in office (16): Rudy Yakym III (R-IN-2); Don Young (R-AK-AL); Alcee L. Hastings (D-FL-20); Devin Nunes (R-CA-22); Jeff Fortenberry (R-NE-1); Marcia L. Fudge (D-OH-11); Tom Reed (R-NY-23); Steve Stivers (R-OH-15); Cedric L. Richmond (D-LA-2); Jackie Walorski (R-IN-2); Filemon Vela (D-TX-34); Charlie Crist (D-FL-13); Antonio Delgado (D-NY-19); Jim Hagedorn (R-MN-1); Debra A. Haaland (D-NM-1); Ron Wright (R-TX-6).

Summary

Main subject: Provides continuing fiscal year 2023 appropriations through December 16, 2022, adds supplemental appropriations for Ukraine, extends expiring health and veterans authorities, reauthorizes Food and Drug Administration user fees, and sets up a compensation program for the Hermit's Peak/Calf Canyon Fire. Division A, Division B, Division D, Division E, Division F, Division G

Its core areas: Continuing appropriations for fiscal year 2023; Supplemental appropriations for Ukraine; Food and Drug Administration user fees for drugs, devices, generic drugs and biosimilar products; Extensions of Medicare, Medicaid and public health authorities; Extensions of Department of Veterans Affairs authorities; Compensation for Hermit's Peak/Calf Canyon Fire claims.

Unexpected Items: 30 provisions

These provisions fall outside the bill’s main subject or apply narrowly. This describes the text; it is not a judgment.

Not related to the bill’s main subject (16)

Sec. 4: Payment to Widows and Heirs of Deceased Members of Congress: Appropriates $174,000 for fiscal year 2023 as a payment to the named beneficiary of a deceased Representative. ($174,000)
Division C, Sec. 101: Extension of FCC Auction Authority: Extends the Federal Communications Commission auction authority in section 309(j)(11) of the Communications Act of 1934 from September 30, 2022 to December 16, 2022.
Division C, Sec. 102: Extension of Authorization for Special Assessment for Domestic Trafficking Victims’ Fund: Extends the authorization for the special assessment for the Domestic Trafficking Victims’ Fund from September 30, 2022 to December 16, 2022.
Division C, Sec. 103: United States Parole Commission Extension: Treats the 35-year period in the Sentencing Reform Act of 1984 as 35 years and 46 days for purposes of the United States Parole Commission.
Division C, Sec. 104: Extension of Commodity Futures Trading Commission Customer Protection Fund Expenses Account: Extends the Commodity Futures Trading Commission Customer Protection Fund expenses account provision from October 1, 2022 to December 16, 2022.
Division C, Sec. 201: Budgetary Effects: Provides that the budgetary effects of Division C and each later division are not entered on the Statutory or Senate PAYGO scorecards and are not estimated for certain budget-enforcement purposes.
Sec. 2005: Conformity assessment pilot program: Replaces the Federal Food, Drug, and Cosmetic Act's accreditation scheme with a program in which the Secretary accredits testing laboratories whose test results are accepted to show device conformity to recognized standards.
Sec. 2006: Reauthorization of third-party review program: Changes the date in the third-party review program provision from October 1 to December 17. The program is not a user fee.
Sec. 5001: Reauthorization of the best pharmaceuticals for children program: Replaces the $25,000,000 annual authorization for the best pharmaceuticals for children program with $5,273,973 for October 1, 2022 through December 16, 2022. The program is not a user fee. ($5,273,973)
Sec. 5002: Reauthorization of the humanitarian device exemption incentive: Changes the date in the humanitarian device exemption incentive provision from October 1 to December 17. The provision is not a user fee.
Sec. 5003: Reauthorization of the pediatric device consortia program: Replaces the $5,250,000 annual authorization for the pediatric device consortia program with $1,107,534 for October 1, 2022 through December 16, 2022. The program is not a user fee. ($1,107,534)
Sec. 5004: Reauthorization of provision pertaining to drugs containing single enantiomers: Changes the date in the provision on drugs containing single enantiomers from October 1 to December 17. The provision is not a user fee.
Sec. 5005: Reauthorization of the critical path public-private partnership: Replaces the $6,000,000 annual authorization for the critical path public-private partnership with $1,265,753 for October 1, 2022 through December 16, 2022. The program is not a user fee. ($1,265,753)
Sec. 5006: Reauthorization of orphan drug grants: Replaces the $30,000,000 annual authorization for orphan drug grants with $6,328,767 for October 1, 2022 through December 16, 2022. The grants are not a user fee. ($6,328,767)
Sec. 5007: Reauthorization of certain device inspections: Changes the date in the device inspections provision from October 1 to December 17. The provision is not a user fee.
Sec. 5008: Reauthorization of reporting requirements related to pending generic drug applications and priority review applications: Changes the date in the reporting requirements on pending generic drug applications and priority review applications from October 1 to December 16. The requirements are not a user fee.

Applies only to a specific place or group (1)

Sec. 144: Provides additional Indian Health Service funding at rates of $16,721,000 and $1,201,000 for staffing and operating facilities opened, renovated, or expanded in fiscal years 2022 and 2023.

Funds a specific named project or event (2)

Sec. 122: Lets the Secretary of Defense transfer up to $3,000,000,000 of unobligated balances to State Department accounts for support of Operation Allies Welcome or any successor operation, with listed funding-rule waivers. ($3,000,000,000)
Sec. 136: Appropriates $2,500,000,000 by transfer from the FEMA Disaster Relief Fund to a new account to carry out the Hermit’s Peak/Calf Canyon Fire Assistance Act, with $1,000,000 of it going to the Inspector General. ($2,500,000,000)

Different amount for specific places or groups (2)

Sec. 126: For the period covered by the Act, extends the Calfed Bay-Delta Authorization Act by one year and replaces the $25,000,000 figure in section 103(f)(4)(A) with $25,650,000.
Division G, Sec. 104: Compensation for victims of hermit’s peak/calf canyon fire: Among the claims provisions, it waives State and local matching-fund requirements for projects responding to the Hermit's Peak/Calf Canyon Fire and sets the Federal share of those project costs at 100 percent.

Exception or delay for a subset (8)

Division A, Sec. 101: Continues fiscal year 2022 funding rates for twelve appropriations Acts, but excludes section 783 of the agriculture Act and applies section 785 of that Act with $125,000,000 in place of $250,000,000.
Sec. 132: Allows the District of Columbia to spend local funds at the rate set in its own fiscal year 2023 local budget act, as modified, instead of the rate that applies under section 101.
Sec. 142: Lets National Park Service heritage partnership funds go to heritage areas established as of September 1, 2022, despite any statutory sunset on assistance and any cap on authorized amounts for those areas.
Sec. 146: Appropriates $1,000,000,000 for Low Income Home Energy Assistance, and directs that $500,000,000 of it be allocated as though total fiscal year 2023 funding were less than $1,975,000,000.
Sec. 157: Rescinds unobligated balances of two earlier national infrastructure investment accounts and re-appropriates equal amounts, available without additional competition to complete funding of previously made awards.
Sec. 1002: Definitions: Excludes from the drug fee definitions applications and products for allergenic extracts licensed before October 1, 2022, and adds a skin-test diagnostic product definition used for a fee exception.
Sec. 1003: Authority to assess and use drug fees: Sets drug fee revenue amounts for fiscal years 2023 through 2027 and exempts skin-test diagnostic products from the human drug application fee and the prescription drug program fee.
Sec. 155: Appropriates $2,000,000,000 for the Community Development Fund limited to major disasters in 2021 or 2022, and states that three provisos of the earlier Act's appropriation do not apply. ($2,000,000,000)

Delays or blocks a specific regulation (1)

Division D, Sec. 401: Extension of moratorium: Changes the date in section 424(a) of title IV of division G of Public Law 113–76 from October 1, 2019 to December 16, 2022, extending a moratorium.

What it does

Division A, Sec. 101: Provides funds for continuing projects and activities at the fiscal year 2022 rate for operations, under the fiscal year 2022 appropriations Acts the section lists.
Sec. 106: Makes the continuing appropriations available until the earliest of enactment of an appropriation for the project or activity, enactment of the applicable fiscal year 2023 appropriations Act without it, or December 16, 2022.
Title I, “Operation and Maintenance, Defense-Wide”: Provides $4,713,544,000 for Operation and Maintenance, Defense-Wide to respond to the situation in Ukraine, of which $3,000,000,000 is for the Ukraine Security Assistance Initiative.
Title III, “Economic Support Fund”: Provides $4,500,000,000 for the Economic Support Fund for assistance for Ukraine, available until September 30, 2024.
Sec. 136: Appropriates $2,500,000,000 to the Federal Emergency Management Agency's Hermit's Peak/Calf Canyon Fire Assistance Account, derived by transfer from a Disaster Relief Fund appropriation in the Coronavirus Aid, Relief, and Economic Security Act.
Sec. 146: Provides an additional $1,000,000,000 for Low Income Home Energy Assistance payments under the Low-Income Home Energy Assistance Act of 1981, available until September 30, 2023.
Division G, Sec. 104: Makes each injured person eligible for compensation from the United States for injury from the Hermit's Peak/Calf Canyon Fire, and establishes an Office of Hermit's Peak/Calf Canyon Fire Claims within the Federal Emergency Management Agency to receive, process and pay claims.
Sec. 1003: Extends the Food and Drug Administration's authority to assess prescription drug user fees through fiscal year 2027 and sets how total fee revenue is calculated for fiscal years 2023 through 2027.
Division D, Sec. 102: Extends the Medicare-dependent hospital program by changing the October 1, 2022 dates in the Social Security Act to December 17, 2022.
Division E, Sec. 101: Extends through September 30, 2024 the Department of Veterans Affairs' authority to collect copayments for hospital care and nursing home care.

Written automatically from the official text by Claude Sonnet 5.5, an AI model. Written 15 Oct 2026 and published after the automatic checks, without a person reading it first. Every line names the section it came from.

Changed after House passage

Compares the bill as passed by the House, 31 Mar 2022, with the final text passed by both chambers. About 2% of the wording the House passed stands in the final text.

Less than a tenth of the final text’s wording was in the text the House passed: 172 of its sections were not in it.

Removed before the final vote (3)

Sec. 2: Requirements with respect to cost-sharing for insulin products:
Sec. 3: Appropriate cost-sharing for certain insulin products under Medicare part D:
Sec. 4: One year-extension on moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates: